`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner
`
`v.
`
`NOVARTIS PHARMA AG, NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owners.
`
`Case: IPR2021-00816
`Patent No. 9,220,631
`
`PATENT OWNERS’ NOTICE OF DEPOSITION OF
`JOEL M. COHEN UNDER 37 C.F.R § 42.53
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2021-00816
`Patent Owners’ Notice of Deposition of Joel M. Cohen
`
`Please take notice that pursuant to 37 C.F.R.§ 42.53, Patent Owners will take
`
`the deposition of Joel M. Cohen upon oral examination. The deposition will be
`
`taken on May 19, 2022 beginning at 10:00 am EDT, via remote videoconference.
`
`The deposition will be recorded by stenographic means by a court reporter licensed
`
`to administer oaths. In accordance with 37 C.F.R. § 42.53(d)(1), the parties have
`
`conferred and agreed upon the date, time and location of the deposition.
`
`Dated: May 4, 2022
`
`
`
`
`
`Respectfully submitted,
`
`/Elizabeth J. Holland/
`Elizabeth J. Holland (Reg. No. 47,657)
`Lead Counsel for Patent Owners
`Allen & Overy LLP
`1221 Avenue of the Americas
`New York, NY 10020
`Tel: 212-610-6375
`elizabeth.holland@allenovery.com
`
`Counsel for Patent Owners Novartis
`Pharma AG, Novartis Technology LLC, and
`Novartis Pharmaceuticals Corporation
`
`2
`
`
`
`
`
`
`
`IPR2021-00816
`Patent Owners’ Notice of Deposition of Joel M. Cohen
`
`CERTIFICATION OF SERVICE
`A copy of this Patent Owners’ Notice of Deposition of Joel M. Cohen
`
`under 37 C.F.R. § 42.53 has been served on Petitioner’s attorneys of record as
`
`follows via electronic mail on May 4, 2022
`
`Elizabeth Stotland Weiswasser (Reg. No. 55,721)
`Anish R. Desai (Reg No. 73,760)
`Natalie Kennedy (Reg No. 68,511)
`Andrew Gesior (Reg No. 76,588)
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue New York, NY 10153
`T: 212-310- 8022
`F: 212-310-8007
`Regeneron.IPR.Service@weil.com
`
`Brian E. Ferguson (Reg No. 36,801)
`Christopher M. Pepe (Reg No. 73,851)
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`Regeneron.IPR.Service@weil.com
`Attorneys for Regeneron Pharmaceuticals, Inc.
`
`Dated: May 4, 2022
`
`By: /Elizabeth J. Holland/
`Elizabeth J. Holland (Reg. No. 47,657)
`Lead Counsel for Patent Owners
`Allen & Overy LLP
`1221 Avenue of the Americas
`New York, NY 10020
`Phone: + 212 610 6365
`Elizabeth.Holland@allenovery.com
`
`3
`
`